Eye drop trial aims to halt worsening vision in kids
NCT ID NCT07164092
Summary
This study is testing whether a low-dose atropine eye drop can slow down the progression of nearsightedness (myopia) in children. Over two years, each child will receive the drop in one eye and a placebo drop in the other to compare results. The goal is to control the condition and potentially reduce future vision problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOPIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.